The invention includes biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant of human serum albumin, methods for the preparation of such fusion polypeptides, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing such fusion polypeptides.

 
Web www.patentalert.com

< MAGE-A3 peptides presented by HLA class II molecules

> Bacterial expression of bowman-birk protease inhibitors and variants thereof

~ 00456